Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 77

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 77
---
.67
    )

    Diluted net loss per share attributable to common stockholders (Note 2)
     
    $
    (1.52
    )
     
    $
    (4.42
    )
     
    $
    (3.67
    )

    Weighted-average number of shares used in calculating net loss per share attributable to common stockholders:

    Basic shares of common stock

    23,654,395

    23,176,098

    22,852,571

    Diluted shares of common stock

    23,654,395

    23,176,098

    22,852,571

See accompanying notes to the consolidated financial statements. 

 F-5

Inogen, Inc. 

Consolidated Statements of Stockholders’ Equity 

(amounts in thousands, except share amounts) 

    Retained

    Accumulated

    Additional

    earnings

    other

    Total

    Common stock

    paid-in

    (accumulated

    comprehensive

    stockholders'

    Shares

    Amount

    capital

    (deficit)

    income (loss)

    equity

    Balance, December 31, 2021

    22,731,586

    $
    23

    $
    299,463

    $
    69,272

    $
    1,469

    $
    370,227

    Stock-based compensation

    —

    —

    12,283

    —

    —

    12,283

    Employee stock purchases

    62,328

    —

    1,691

    —

    —

    1,691

    Restricted stock awards issued,    net of forfeitures

    (5,134
    )

    —

    —

    —

    —

    —

    Vesting of restricted stock units

    141,728

    —

    (1,252
    )

    —

    —

    (1,252
    )

    Shares withheld related to net   restricted stock settlement

    (3,019
    )

    —

    (103
    )

    —

    —

    (103
    )

    Stock options exercised

    14,154

    —

    44

    —

    —

    44

    Net loss

    —

    —

    —

    (83,772
    )

    —

    (83,772